Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001214659-25-016261
Filing Date
2025-11-12
Accepted
2025-11-12 08:00:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7848
  Complete submission text file 0001214659-25-016261.txt   9522
Mailing Address 600 THIRD AVENUE 2ND FLOOR NEW YORK NY 10016
Business Address 600 THIRD AVENUE 2ND FLOOR NEW YORK NY 10016 212-601-9792
Sio Capital Management, LLC (Filed by) CIK: 0001482416 (see all company filings)

EIN.: 204586565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 215-948-4119
Aprea Therapeutics, Inc. (Subject) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91159 | Film No.: 251469026
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)